✦ Built for Radiation Oncology

The AI operating system for your radiation oncology clinic.

MEDSIMPLIFY unifies the entire course of care — from diagnosis and simulation to the final fraction — into one mobile-first workspace, with AI that reads the chart so your team doesn't have to.

Mobile-first AI-native workflows Built with clinicians
9:415G ▮▮▮

Jane Doe

MRN RT-20381 · Radiation Oncology
✦ AI
JD
Jane Doe 39 yrs · Female · DOB 03/14/1987 Breast cancer · C50.111
cT2 N1 M0 · Stage IIB ER+ / PR+ / HER2− PIK3CA E545K

Today · Fraction 14 of 25

VMAT · DIBH · Linac 256% complete
AI: On-treatment visit due today. Wk-3 skin check outstanding; dermatitis risk model: moderate.
Home Timeline Plan Summary Dose
One platform

Five AI capabilities, one course of care

Every screen below is from a single, continuous record — patient Jane Doe, 39, right breast cancer (ICD-10 C50.111) with Foundation Medicine comprehensive genomic profiling.

AI Patient Timeline

Every event — imaging, pathology, genomics, RT — auto-extracted and ordered.

See it →
AI Planning · Sim · Treatment Tracker

Live status from CT-sim to final fraction, with AI bottleneck alerts.

See it →
AI Patient Summary

A one-screen clinical picture, regenerated the moment anything changes.

See it →
AI Treatment Summary

End-of-treatment documentation drafted in seconds, ready to sign.

See it →
AI 2D/3D Dose Visualization

Isodose, DVH, and rotatable 3D dose review — on a phone.

See it →
Feature 01

AI Patient Timeline

MEDSIMPLIFY's AI reads referrals, pathology reports, genomic profiles, and RT records, then assembles a chronological, source-linked timeline. No more scrolling through PDFs to reconstruct the story.

  • Automatic event extraction from scanned documents, HL7/FHIR feeds, and dictations.
  • Genomics-aware: Foundation Medicine CGP results land as structured, actionable events.
  • Tap any event to open the underlying source document.
9:415G ▮▮▮

Patient Timeline

Jane Doe · 39 F · C50.111
✦ AI
AI: 42 events extracted from 12 source documents. 2 new since your last review.
Feb 3, 2026 Screening mammogram — BI-RADS 5

2.8 cm spiculated mass, central right breast.

Feb 10, 2026 Core biopsy — Invasive ductal carcinoma

Central portion, right breast (C50.111). Grade 2. ER 95% · PR 80% · HER2 1+ (neg) · Ki-67 22%.

Feb 24, 2026 Foundation Medicine CGP (F1CDx)

PIK3CA E545K · GATA3 fs · TMB-Low (3 Muts/Mb) · MS-Stable · BRCA1/2 not detected.

Mar 5, 2026 Lumpectomy + SLNB

Margins negative. 1/3 sentinel nodes positive → pT2 pN1a.

Apr 28, 2026 CT Simulation — DIBH

Supine, breast board, surface-guided DIBH coaching completed.

May 8, 2026 RT Course started — Fraction 1

Right breast + regional nodes, VMAT, 40.05 Gy / 15 fx + boost.

Filter events Open sources
Home Timeline Plan Summary Dose
Feature 02

AI Planning · Simulation · Treatment Tracker

One live view of where every patient sits in the RT pipeline — simulation, contouring, planning, physics QA, and daily treatment — with AI watching for stalls before they cost a start date.

  • Milestone tracking with owners, due dates, and automatic status from your TPS and R&V feeds.
  • Fraction-by-fraction progress, missed-fraction alerts, and setup-deviation trends.
  • AI bottleneck alerts predict slipped start dates 3–5 days early.
9:415G ▮▮▮

Care Tracker

Jane Doe · RT Course #1
✦ AI

Pipeline

CT SimulationDIBH · breast board · SGRT ref capturedApr 28
ContouringAI auto-segmentation · MD approvedApr 30
Treatment PlanningVMAT · 2 arcs · plan v3 approvedMay 5
Physics QAPatient-specific QA passed · γ 99.2%May 6
14TreatmentFraction 14 of 25 · on scheduleends Jun 11

Fraction progress

14/25 fractions
Delivered22.4 Gy of 40.05 Gy
Missed fx0
Avg setup shift1.4 mm
DIBH compliance98%
AI: Setup deviation trending up on lateral axis (2.1 mm over last 3 fx). Suggest surface-guidance recalibration before fx 15.
Home Timeline Plan Summary Dose
Feature 03

AI Patient Summary

The whole clinical picture on one screen — demographics, staging, receptors, and Foundation Medicine genomics — with an AI narrative that regenerates the moment new data lands.

  • Structured genomics: CGP findings parsed into alterations, biomarkers, and therapy signals.
  • Always current: new pathology or labs trigger an automatic summary refresh with change highlights.
  • Source-grounded: every AI sentence cites the document it came from.
9:415G ▮▮▮

Patient Summary

Generated 2 min ago · v14
✦ AI
JD
Jane Doe 39 yrs · Female · MRN RT-20381
DiagnosisMalignant neoplasm, central portion of right female breast
ICD-10C50.111
StagepT2 pN1a M0 · IIB
HistologyInvasive ductal ca., Grade 2

Receptors & Genomics · Foundation Medicine

ER 95% PR 80% HER2 1+ (neg) Ki-67 22%
PIK3CAE545K — pathogenic ⚑
GATA3frameshift alteration
BRCA1/2not detected
TMBLow · 3 Muts/Mb
MSIStable
AI summary: 39-year-old woman with pT2 pN1a Stage IIB, ER+/PR+/HER2− invasive ductal carcinoma of the central right breast (C50.111), s/p lumpectomy + SLNB with negative margins. Foundation Medicine CGP shows PIK3CA E545K — flagged for medical-oncology review re: targeted-therapy eligibility. Currently on adjuvant RT, fx 14/25. 6 sources
View changes Share to team
Home Timeline Plan Summary Dose
Feature 04

AI Treatment Summary

End-of-treatment documentation used to take an hour per patient. MEDSIMPLIFY drafts a complete, structured treatment summary — prescription, technique, dosimetry, toxicity, and follow-up plan — ready for physician sign-off in seconds.

  • Auto-compiled dosimetry: prescription, delivered dose, and OAR statistics pulled straight from the plan.
  • Toxicity capture: CTCAE-graded on-treatment findings folded in automatically.
  • One-tap export to PDF and to the referring physician.
9:415G ▮▮▮

Treatment Summary

Draft · awaiting MD signature
✦ AI

Course of Radiation Therapy

SiteRight whole breast + boost
Prescription40.05 Gy / 15 fx (2.67 Gy/fx)
BoostTumor bed 10 Gy / 4 fx
TechniqueVMAT · 6 MV · DIBH · SGRT
DatesMay 8 – Jun 11, 2026
Missed fx0 · 100% compliance

Plan quality & OAR doses

PTV V95%97.6% ✓
Mean heart dose1.1 Gy ✓
Ipsilateral lung V2016.2% ✓
Contralateral breast mean0.4 Gy ✓
Max skin dose105.8%

Toxicity (CTCAE v5)

Radiation dermatitisGrade 1 · wk 4
FatigueGrade 1
AI: Follow-up drafted — clinical exam at 1 mo, mammogram at 6 mo, endocrine therapy per medical oncology, PIK3CA finding cross-referenced in survivorship plan.
Export PDF Sign & send
Home Timeline Plan Summary Dose
Feature 05

AI 2D/3D Dose Visualization

Review isodose distributions, dose–volume histograms, and a rotatable 3D dose cloud from anywhere. AI pre-reads the plan and flags anything approaching an OAR constraint before you even open it.

  • 2D axial / sagittal / coronal isodose wash with labeled dose levels.
  • Interactive DVH for targets and organs at risk, with constraint lines.
  • 3D dose cloud with beam geometry — pinch, rotate, and slice on a phone.
9:415G ▮▮▮

Dose Review

Plan v3 · approved · 40.05 Gy
✦ AI
Axial 2D3D viewDVH
Isodose — 105% — 95% — 80% — 50% — 20% Med tangent R L PTV
Slice 42 / 88 · CT sim Apr 28DIBH ✓

Dose–Volume Histogram

0 25 50 75 100 0 20 40 60 Dose (Gy) Volume (%) PTV Ipsi lung Rx 40.05 Gy
PTV (breast) Ipsilateral lung Heart Contralat. breast

3D dose cloud

VMAT arc 1 arc 2 PTV
Drag to rotate · pinch to zoom⟲ 3D
AI plan check: All OAR constraints met. Nearest approach: ipsilateral lung V20 at 16.2% vs 20% limit (81% of budget). No hotspots >107%.
Home Timeline Plan Summary Dose
Why clinics choose MEDSIMPLIFY

Less time in the chart. More time with patients.

3.2 hrs
saved per clinician, per day, on chart review and documentation
Illustrative design target
<30 sec
to generate a source-grounded patient or treatment summary
Illustrative design target
100%
of RT milestones tracked from simulation through final fraction
Illustrative design target
Mobile
first — full plan review, dose viz, and sign-off from your phone
iOS · Android · Web
Get in touch

See MEDSIMPLIFY on your own clinic's workflow

We'll walk your team through a live demo — timeline, tracker, summaries, and dose visualization — and map it to how your department runs today.

Request a demo →